AMY WILLIAMS: Open Payments
NPI 1679296396 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 57 payments from 12 companies in 2025. Trend: 2023 $849 · 2024 $376 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $324 |
| Novo Nordisk Inc | 5 | $199 |
| AstraZeneca Pharmaceuticals LP | 4 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $98 |
| Stryker Corporation | 1 | $64 |
| Amgen Inc. | 2 | $36 |
| ViiV Healthcare Company | 2 | $31 |
| PFIZER INC. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
Products named: VRAYLAR, Ozempic, BREZTRI, CAPLYTA, CLOTTRIEVER BOLD CATHETER, UBRELVY, FARXIGA, OTEZLA.
Industry payments across SC — which companies pay providers there.
